1. A randomized trial comparing limited-excision conisation to Large Loop Excision of the Transformation Zone (LLETZ) in cervical dysplasia patients.
- Author
-
Kolben TM, Etzel LT, Bergauer F, Hagemann I, Hillemanns P, Repper M, Kaufmann AM, Sotlar K, Kolben T, Helms HJ, Gallwas J, Mahner S, and Dannecker C
- Subjects
- Adult, Cervix Uteri pathology, Conization, Equivalence Trials as Topic, Female, Germany, Humans, Middle Aged, Neoplasm Grading, Papillomavirus Infections complications, Tumor Burden, Uterine Cervical Dysplasia virology, Uterine Cervical Neoplasms virology, Young Adult, Cell Transformation, Viral, Cervix Uteri surgery, Margins of Excision, Papillomavirus Infections pathology, Uterine Cervical Dysplasia pathology, Uterine Cervical Neoplasms pathology
- Abstract
Objective: To show noninferiority of a limited-excision (resection of the dysplastic lesion only) vs. classical Large Loop Excision of the Transformation Zone (LLETZ)., Methods: In this prospective, randomized, multicenter trial, women with human papillomavirus (HPV) positive cervical intraepithelial neoplasia grade 3 were randomized into two groups (1:1). Primary outcome was the rate of negative HPV tests after 6 months, secondary outcomes included cone size, complete resection rates as well as cytological and histological results after 6 and 12 months. A sample size of 1,000 was calculated to show noninferiority of the limited-excision compared to the LLETZ group using a noninferiority margin of 5%. Enrollment was stopped after 100 patients due to slow accrual., Results: Patients in the limited-excision group did not show a lower number of negative HPV tests (78% [LLETZ]-80% [limited-excision]=-2%; 90% confidence interval=-15%, 12%). The limited-excision resulted in a substantially lower cone size (LLETZ: 1.97 mL vs. limited-excision: 1.02 mL; p<0.001) but higher numbers of involved margins (LLETZ: 8% vs. limited-excision: 20%). Although postoperative cytological results slightly differed, histological results were similar in both groups. One limited-excision patient received immediate re-conisation, whereas one patient in each group was scheduled for re-conisation after 6 months., Conclusion: The limited-excision could represent a promising option to reduce the surgical extent of conisations while maintaining oncological safety. The trial was not sufficiently powered to reach statistical significance due to early termination. Nevertheless, the study provides important insights in the feasibility of a limited-excision and could serve as a pilot study for future trials., Trial Registration: German Clinical Trials Register Identifier: DRKS00006169., Competing Interests: The authors declare no financial support of this study. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. Sven Mahner is involved in research support, advisory board, honoraria and travel expenses from AstraZeneca, Colvis, Medac, MSD, PharmaMar, Roche, Sensor Kinesis, Tesaro and Teva., (Copyright © 2019. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology.)
- Published
- 2019
- Full Text
- View/download PDF